skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Slate has changed into almost total office reit since your last comment on this reit. TDWaterhouse has a buy recommendation with a 24% total 12 month return and rank it medium risk. Payout ratio is 85%. I exited H&R earlier this year and now wish to accumulate again in reits. Looking at the 2, how would you rate them on a risk/return basis.
As always, thanks
Read Answer Asked by Cyril on November 25, 2015
Q: Nobilis has deferred the issue of their quarterly financial statements again. They have indicated that the delay related to their auditors and that they did not believe that any adjustments would be material. I listened to their conference call several weeks ago and at that time their explanation for potential adjustments and their affect made me think that they were probably immaterial to their results and consequently could be ignored. But this later announcement has me concerned. What do you think. Thanks
Mike
Read Answer Asked by Michael on November 25, 2015
Q: CRH Medical announces they have secured a $33M revolving line of credit with Bank of Nova Scotia at 2.5-3% and are using the funds to repay loans from Knight Therapeutics $22M and Bloom Burton Healthcare $2M that had interest rates of 10-12% with a resulting estimated savings in finance expenses of $2.5M. Good news. The company has said they will use the balance of funds for future acquisitions. Do you expect an acquisition will occur before year end and would the asset to be acquired be in the US? Thanks
Read Answer Asked by Gordon on November 25, 2015
Q: What financial engineering encourages companies like Transalta and Enbridge to " drop down" assets into majority owned subsidiaries? Thanks
Read Answer Asked by JACK on November 25, 2015
Q: Good Morning Peter and team, I'm holding a number of stocks which I could charitably classify as "dogs". They include, ZAR,MGO,RET.A,NGD,TCK.B. All of these now make up less than 1% of my portfolio. On the brighter side I do have a few winners. (Thanks 5I) I'm up to 9% on CSU and 7.5% on ESL. Should I sell all of the dogs and trim back to 5% or so on the winners or should I try cover more of my losses and sell all of my winners. I would then buy back to 5% in 30 days. Thanks for your advice. Rod
Read Answer Asked by Rod on November 25, 2015
Q: Hi Friends! I have a few energy names and I'm not sure whether they are worth a hold? I welcome your comments...
Read Answer Asked by Ian on November 25, 2015
Q: Hi Peter and Crew,
Just got in under the wire and renewed my membership for two more years. Your service and advice is exceptional and I couldn't be happier.
Thanks a million
Read Answer Asked by Ivan on November 25, 2015
Q: Hi
Do you have any idea why Face book is coming down. And even VISA seems to have that tendency?
Margita
Read Answer Asked by Margita Elisabet on November 25, 2015
Q: HI
Why are BCE and Telus a recommended "buy" when they both have not met their estimates.
Margita
Read Answer Asked by Margita Elisabet on November 25, 2015
Q: I would like to send a thanks to Michael for providing insight into Inspira's reimbursement protocol, following my recent question. I appreciate the information.
Thanks.
Read Answer Asked by Steven on November 25, 2015
Q: I hold this stock and wonder if you would recommend a switch to another in the same space that you might recommend. I do own Mainstreet Equity. In August you said MEQ was a good company still. Thank you.
Read Answer Asked by Bill on November 25, 2015
Q: Had a good conversation with someone who dealt with this company at a corporate level and they quite liked them. How are their numbers?
Read Answer Asked by Deborah on November 25, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!